Session Keynote Speakers

Please find below an overview of all the confirmed Session Keynote Speakers, in alfabetical order. New Session Keynote Speakers will be added regularly.

At a later date the abstract titles will be added to each of the Session Keynote Speakers. 

 

Dr. Mark Allenby, Queensland University of Technology (QUT)

Dr Mark C Allenby is a Lecturer and Advance Queensland research fellow at Queensland University of Technology coupling tissue systems models and bioimage analyses to engineer improved medical treatments using experimental and computational approaches. Allenby is an investigator in the Herston Biofabrication Institute at the Royal Brisbane & Women's Hospital in Australia. URL: https://staff.qut.edu.au/staff/mark.allenby.

Prof. Eben Alsberg, University of Illinois at Chicago


Dr. Alsberg is the Richard and Loan Hill Professor of Bioengineering, Orthopaedics, Pharmacology, and Mechanical & Industrial Engineering at the University of Illinois at Chicago. His lab focuses on engineering new technologies to regenerate tissues and treat diseases through development of novel biomaterials and microenvironments. He’s co-authored >130 peer reviewed papers and book chapters, and his work has been recognized with AIMBE College of Fellows membership, the Ellison Medical Foundation New Scholar in Aging Award, the Crain’s Cleveland Business Forty Under 40 Award, and Visiting Professorships in Korea and Israel.

Prof. Paula M Alves, iBET - instituto Biologia Experimental e Tecnologica

Paula Alves is the CEO of iBET and Professor at NOVA University of Lisbon; She holds a Ph.D. in Biochemical Engineering and a BSc in Biochemistry; Working in Animal Cell Technology since 1990, Professor Alves’ research integrates cell metabolism understanding with biochemical engineering for the improvement of bioprocesses for production of biopharmaceuticals, also focusing on the development of new tools for pre-clinical research. She is currently the President of the European Society for Animal Cell Technology. Published over 250 papers, 35 book chapters, supervised 36 PhD students. In 2009 she received the Scientific Merit Award from NOVA University of Lisbon.

Prof. Vicente Andrés, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC)


Dr. Andrés holds a PhD in Biology from Barcelona University and had postdoctoral training in Harvard University (1991-1993) and Tufts University (1993-1995). He was appointed Assistant Professor by Tufts University (1995-2000) and joined in 1999 the Biomedicine Institute of Valencia-CSIC. In 2009, he joined the Spanish National Centre for Cardiovascular Research (CNIC), where he heads the Basic Research Department since 2015. He investigates cardiovascular disease and the role of lamin A/C in health and disease, including Hutchinson-Gilford progeria syndrome. Since 2015, he is member of the Progeria Research Foundation Medical Research Committee.

Dr. Ilia Bozo, Histograft, LLC


Dr. Bozo, MD,PhD, MBA is a maxillofacial surgeon, researcher in regenerative medicine field and biotechnology entrepreneur. Being involved in R&D projects in gene therapy and clinical practice in maxillofacial surgery, he co-founded “Histograft”, a Russian biotech company, with R.Deev, A.Isaev and HSCI investment in 2015. Four years later, the company brought to clinical practice the world’s first gene-activated bone substitute based on octacalcium phosphate and plasmid DNA encoding VEGFA gene. The product has been proven to be safe and effective for bone grafting and reconstructive surgery. Ongoing researches cover 3D-printing of gene-activated matrices and hydrogel platforms for non-viral gene delivery.

Dr. Christopher Breuer, Nationwide Children's Hospital


Dr Breuer is the Director of the Regenerative Medicine Program at Nationwide Children's Hospital. He is a Tenured Professor of Surgery at The Ohio State University and holds the Nationwide Endowed Chair for Surgical Research. His research focuses on cardiovascular tissue engineering and its application in the treatment of congenital heart disease.

Prof. Conor T Buckley, Trinity College Dublin

Conor Buckley is Principal investigator (PI) in the Trinity Centre for Biomedical Engineering and the Advanced Materials and Bioengineering Research (AMBER) Centre at Trinity College Dublin, Ireland. His research focuses on novel biomaterials, biofabrication and cell-based strategies for tissue regeneration (https://www.buckleylab.eu/). He has published 70 international peer reviewed journal articles and over 180 conference publications. He recently received a European Research Council Award (ERC) Consolidator award to develop personalised medicine approaches to regenerating the intervertebral disc using gene activated biomaterials and in silico predictive modelling.

Prof. Joaquim Cabral, Institute for Bioengineering and Biosciences, Instituto Superior Técnico, University of Lisbon, Portugal

Joaquim Cabral is a Distinguished Professor of Instituto Superior Técnico, University of Lisbon, Portugal. He was the Founding Head of Department of Bioengineering and Founding Director of the Institute for Bioengineering and Biosciences. He is graduated in Chemical Engineering with a PhD and “Habilitation” degrees in Biochemical Engineering in 1983 and 1988, respectively. He was a post-doctoral fellow at Massachusetts Institute of Technology (1983-1984). He joined IST faculty as Assistant Professor in 1984 and became Associate Professor in 1987 and Full Professor of Chemical and Biological Engineering in 1992. He has authored more than 580 publications (WoS h index 55).

Prof. dr. Antonio Campos, Departmen of Histolgy, School of Medicine University of Granada, Spain

Antonio Campos is Full Professor of Histology at the University of Granada. He has been president of the Spanish Society of Histology, Dean and director of the National Institute of Health Carlos III where he promoted new models of biomedical investigation programs.  Promoter of tissue engineering, his group has created artificial tissues that have already been transferred to the clinic.  He has published relevant books and papers in high impact factor journals related to tissue engineering and Medical Education. Member of the Spanish Royal Academy of Medicine he has received three honoris causa doctorates in Argentina, Dominican Republic and Portugal.

Prof. Sing Yian Chew, Nanyang Technological University


Dr. Sing Yian CHEW is an Associate Professor at School of Chemical & Biomedical Engineering and Lee Kong Chian School of Medicine at Nanyang Technological University, Singapore. Her most significant contribution is in the field of scaffold-mediated delivery of gene-silencing and biomimicking physical signals for neural tissue regeneration and remyelination. Dr. Chew serves as Editorial Board member in Tissue Engineering, Frontiers in Bioengineering and Biotechnology – Biomaterials, Journal of Biomedical Materials Research Part A, Drug Delivery and Translational Research, Experimental Neurology and Journal of Tissue Engineering. In addition, Dr. Chew is an Associate Editor in ACS Applied Materials & Interfaces."

Dr. Peter Coffey, UCL, London


Dr. Coffey received his D. Phil at Oxford University and was a member of the faculty at Oxford and later the University of Sheffield as Lecturer and Senior Lecturer. He was formerly Professor and Head of Ocular Biology and Therapeutics at the Institute of Ophthalmology at University College London, where he also served as Chair of Cellular Therapies and Visual Science. Dr. Coffey has received many honors and awards, including the prestigious Estelle Doheny Living Tribute Award in 2009, Retinitis Pigmentosa International's Vision Award in 2009, the CIRM Leadership Award in 2010, and the NYSCF Roberston Prize in 2011.

Prof. Sabine Costagliola, IRIBHM-ULB


Sabine Costagliola is Research Director at IRIBHM, Université Libre de Bruxelles (ULB), Belgium. She is laureate of several prizes for her contribution to thyroid and endocrine research and has a significant track record of high-profile publications in international Journals in the field. The main focus of her research is the molecular dissection of signaling mechanisms that control morphogenetic processes and gene networks involved in thyroid organogenesis with a working strategy combining several experimental models including Zebrafish and organoids.

Prof. Dr. Magali Cucchiarini, Center of Experimental Orthopaedics, Saarland University Medical Center


Magali Cucchiarini, PhD, is a Group Leader and Vice-Director of the Center of Experimental Orthopaedics, Saarland University, Homburg/Saar, Germany. She graduated from the University of Nice-Sophia Antipolis, France (1992) and received her PhD from this University (Virology and Molecular Biology, summa cum laude, 1995). She was a senior post-doctoral fellow at the Harvard Institutes of Medicine, Boston, USA (HIV gene therapy) and at the Department of Internal Medicine, University Hospital Inselsspital, Bern, Switzerland (EU project, HCV vaccination). Her research interest is to generate cell-, gene-, and tissue engineered-based systems for musculoskeletal disorders.

Prof. Dr. Laura De Laporte, DWI - Leibniz Institute for Interactive Materials

Laura De Laporte designs Advanced Biomedical Systems that direct the interaction with cells. She studied Chemical Engineering in Ghent, where she got the tissue engineering microbe. During her PhD at Northwestern University, she engineered guiding implants for nerve regeneration, while her postdoc at EPFL in Jeffrey Hubbell’s group focused on smart hydrogels. Currently, she is a Leibniz Professor at the RWTH University and DWI-Leibniz Institute for Interactive Materials (Aachen, Germany). In her ERC Starting Grant Anisogel, her team designs low-invasive, polymeric hydrogel therapies that orient after injection to repair anisotropic tissues. In addition, dynamic hydrogels are created to study mechanobiology.

Prof. Paul Dalton, University of Würzburg


Paul Dalton is a Professor in Biofabrication at the University of Würzburg. Graduating from Curtin University in Perth, Australia, he was part of a bioengineering team at the Lions Eye Institute that successfully took an artificial cornea from concept to the clinic. His career has an international perspective, with post-docs at the University of Toronto and RWTH-Aachen followed by research scientist positions at the University of Southampton and Shanghai Jiao Tong University. He invented and developed melt electrowriting as a distinct class within 3D printing with the Queensland University of Technology and has over 25 years’ experience across several disciplines.

Dr. David Dean, The Ohio State University

In 1993 David Dean’s PhD thesis presented a template-based method for producing average 3D organ surface images. As a postdoctoral researcher at New York University he used average skull images as targets for surgical simulation and intra-operative guidance. Later at Case Western Reserve University he was the first person to use average surfaces to design and 3D print patient-specific cranial implants. His regenerative medicine research incorporates skeletal progenitor cells and 3D printing resorbable biomaterials. Since 2013 his research at The Ohio State University has included 3D printed NiTi for stiffness-matched skeletal fixation devices and Mg alloys for resorbable skeletal devices.

Prof. Dr. Georg N. Duda, Julius Wolff Institut, Charité - Universitätsmedizin Berlin


Vize-Speaker Berlin Institute of Health Center for Regenerative Therapies (BCRT) Spokesperson Einstein Centre Regenerative Therapies (ECRT) & Berlin-Brandenburg School for Regenerative Therapies (BSRT). Immune-therapeutics (including a diagnostic kit identifying healing problems), expertise in mechano-biologically optimized healing, guided tissue regeneration by biomaterial scaffolds and bone formation induced by stress-relaxing scaffolds are our research foci. Findings of principles in bone healing are transferred to muscle and ligament regeneration. Immuno-therapeutic and mechano-therapeutic cues open novel avenues for regenerative therapies to restore tissue homeostasis in medical challenged patient settings.

Prof. Garry P. Duffy, National University of Ireland Galway


Professor Garry Duffy is Personal Professor in Anatomy & Regenerative Therapies, within the School of Medicine at the National University of Ireland Galway. He leads the Duffy Lab at NUI Galway, which is focused on developing advanced biomaterials and devices to facilitate targeted delivery and future clinical translation of cell and drug based therapeutics to treat chronic diseases.

Prof. Dr. Denis Evseenko, University of Southern California


Dr. Denis Evseenko is currently an Associate Professor of Orthopaedic Surgery, Stem Cell Research and Regenerative Medicine at USC. Dr Evseenko was trained in both medicine and molecular pharmacology. His research focuses on the development of novel translational stem cell and small molecule-based approaches for prevention of arthritis and restoration of damaged articular cartilage. Dr Evseenko has been involved in translational research for over 10 years and is the author of numerous peer-reviewed research articles, presentations and patents.

Prof. Thomas Eschenhagen, University Medical Center Hamburg Eppendorf, Institute of Experimental Pharmacology and Toxicology, and German Centre for Cardiovascular Research (DZHK)


Professor Eschenhagen, MD, trained in Cardiology in Hannover and specialized in Experimental Pharmacology and Molecular Biology. He is Director of the Department of Experimental Pharmacology and Toxicology, University Medical Center Hamburg Eppendorf, Chairman German Centre for Cardiovascular Research and currently President ISHR-International. He is member of the German Academy of Science Leopoldina. His research is funded through grants from various public bodies, including an ERC AG. He published >320 papers and textbook chapters including leading pharmacology textbooks. His research focusses on molecular cardiology with a focus on heart failure, stem cells and tissue engineering, a technology he pioneered in 1994.

Dr. Donald O. Freytes, NC State/UNC-CH


Dr. Freytes’ laboratory focuses on the design and testing of bioengineered tissues mainly composed of pluripotent stem cell derived repair cells and tissue specific extracellular matrix scaffolds. The overall goal is to develop new strategies to assemble and test bioengineered constructs capable of restoring tissue function. The major goals of the laboratory are: 1) to harness the power of tissue specific extracellular matrices to guide stem cell differentiation and/or tissue remodeling in vitro and in vivo; and 2) to understand and harness the interaction between inflammatory cells and bioengineered tissue constructs in order to improve incorporation and survival.

Prof. Dr. Benjamin Gantenbein, University of Bern

Prof Benjamin Gantenbein is heading the Tissue Engineering for Orthopedics & Mechanobiology (TOM) group at the Medical Faculty at the University of Bern (UBern). Prof Gantenbein acquired experience in modern concepts of tissue engineering and regenerative medicine. He is active in the field of tissue engineering, stem cell research (www.stemcellsbern.ch) using a wider range of bone & joint tissues. He teaches lectures on Tissue Engineering in the Biomedical Masters course at UBern and also teaches regenerative medicine at the University of Fribourg and the University of Basel.

Dr. Debby Gawlitta, University Medical Center Utrecht

Debby Gawlitta holds a position as Associate Professor heading her lab in the Regenerative Medicine Center Utrecht. She is affiliated with the department of 'Oral and Maxillofacial Surgery' of the University Medical Center Utrecht. Maxillofacial bone and cartilage regeneration are her research foci, with particular expertise in endochondral bone regeneration from a cartilage template and vascularized bone regeneration. Research keywords include clinical translation, biomaterials, stem/progenitor cells, bioreactors, and 3D bioprinting. Her research was supported by a.o. a prestigious Dutch Veni innovation grant and an AO startup grant.

Prof. Dr. Bernd Giebel, Institute for Transfusion Medicine

Bernd Giebel received his PhD 1996 at the University zu Köln in Developmental Biology. From 1999-2008 he worked at the Heinrich-Heine-University of Düsseldorf on human hematopoietic stem and progenitor cells and set up his own group. Continuing his stem cell research, in 2008 BG moved to the University Hospital Essen and as a 2nd topic started to work with EVs.

Prof. May Griffith, Université de Montréal

May Griffith is a professor at the Dept. of Ophthalmology, Université de Montréal, located at the Maisonneuve-Rosemont Hospital Research Centre. MG is mainly recognized for leading a multinational, interdisciplinary team that achieved the world’s first successful regeneration of the human cornea, a tissue that does not regenerate itself. MG and her team used cell-free recombinant human collagen implants that stimulated the patients’ endogenous cells to regenerate a fully functional, innervated neo-cornea as an alternative to corneal transplantation using allografts. For effective clinical translation, MG has teamed-up with world renowned corneal researchers and in efforts to eradicate corneal blindness globally.

Prof. Jerome Guicheux, INSERM U1229-RMeS "Regenerative Medicine and skeleton research centre"

Jérôme Guicheux (50 yo, PhD-DSc 97’) is full professor/senior research director at the French national institute for health and medical research (INSERM). He is director of the research center RMES “regenerative medicine and skeleton” (120 people, INSERM U1229, Nantes, France). He is coordinator of the French INSERM osteoarthritis network. He is a member of the board of directors of OARSI and Regenerate-Biospine. He has authored more than 190 indexed publications (google scholar H-index 60, total citations >9000). His research focuses on the pathophysiology of skeletal tissues and biomaterials/stem cells-based regenerative medicine of cartilage and intervertebral disc. Researcher ID: F-7767-2013

Dr. Johannes Hackethal, THT Biomaterials GmbH

Dr. Hackethal finished his Master studies in “Tissue Engineering and Regenerative Medicine” at FH Technikum Vienna, Austria and “Medical biology” at Linköping University, Sweden. His doctoral thesis was performed at BOKU Vienna, Austria and the Ludwig-Boltzmann-Institute for Experimental and Clinical Traumatology under supervision of Prof.Dr. Heinz Redl (Hackethal et al., 2017. TEC 23(5); Hackethal et al., 2018. Advances in Experimental Medicine and Biology, DOI 10.1007/97898113094721, PCT/EP2019/058534). After finishing pHD, in June 2020, Dr. Hackethal founded THT Biomaterials GmbH, with the aim, to realize an affordable, sustainable and personalized Medicine by use of non-cellular human proteins from placenta.

Dr. Yan Yan Shery Huang, University of Cambridge


Dr Yan Yan Shery Huang leads the Biointerface group at the Department of Engineering, University of Cambridge. She obtained MEng degree in Materials Science and Engineering from Imperial College London; then completed her PhD thesis in the field of Experimental Soft Matter under theoretical physicist, Prof Eugene Terentjev at the University of Cambridge. After graduating from her PhD in 2011, she was awarded an Oppenheimer Fellowship and a Homerton College Junior Research Fellowship. She is a recipient of an ERC-starting grant award, and is a fellow of the Institute of Materials, Minerals and Mining (FIMMM).

Dr. Amanda Hummon, The Ohio State University


Amanda Hummon earned her A.B. in chemistry at Cornell University and her Ph.D. in analytical chemistry at the University of Illinois, in the laboratory of Prof. Jonathan V. Sweedler. She completed her postdoctoral work at the National Cancer Institute. She is currently an associate professor in the Department of Chemistry and Biochemistry and the Comprehensive Cancer Center at The Ohio State University. Her laboratory develops mass spectrometric methods to explore cancer tissues, cell cultures, and organoids. She has been recognized with an NSF CAREER award, the Presidential Early Career Award for Scientists and Engineers (PECASE), and a Fulbright Scholar Award.

Prof. Gunil IM, Dongguk University


Dr. Im is currently Professor in Department of Orthopaedics and Director of Integrative Research Institute for Regenerative Biomedical Engineering, Dongguk University, Goyang, Korea. Dr. Im has been working on the field of osteoarthritis, stem cell and cartilage regeneration of since 1996. He has published 150 peer-reviewed scientific papers in international journals and holds 18 national and international patents. Dr. Im has been performing multidisciplinary research in cooperation with scientist and engineers of various fields to translate the research product into clinical application. He has participated in global academic activity in the field of musculoskeletal research during last two decades.

Prof. Jinah Jang, Pohang University of Science and Technology

Dr. Jinah Jang received her PhD at Pohang University of Science and Technology (POSTECH) in Korea, and trained as postdoctoral fellow in POSTECH and Institute for Stem Cell and Regenerative Medicine at University of Washington. She has joined the POSTECH in 2017 as an assistant professor in the Creative IT Engineering, Mechanical Engineering, and School of Interdisciplinary Bioscience and Bioengineering. She has published 57 peer-reviewed articles in journals including Science Advances, Nature Communications, and Biomaterials (H-index: 24). Her research interest lies in engineering the functional human tissues using high-performance stem cells and printable biomaterials via the 3D bioprinting technology.

Prof. Julian Jones, Imperial College London

Julian Jones leads a research group on bioactive glasses and hybrids, particularly 3D scaffolds and therapeutic nanoparticles. He has >130 articles and 4 patent applications and has co-edited three biomaterials text books. He was elevated to Fellow of the Society for Glass Technology in 2018, Fellow of the American Ceramics Society in 2015; was awarded an ISCM (International Society for Ceramics in Medicine) Excellence Award in 2016; the 2014 Vittorio Gottardi Award from the International Commission on Glass (ICG). He is Chair-elect of the Bioceramics Division of the American Ceramics Society and Editor of the RSC Biomaterials Science Book Series.

Prof. David Kaplan, Tufts University

David Kaplan is the Stern Family Endowed Professor of Engineering at Tufts University, Distinguished University Professor, and Professor and Chair of the Department of Biomedical Engineering. His research focus is on biopolymer engineering to understand structure-function relationships and on tissue engineering and regenerative medicine. His lab has published over 900 peer reviewed papers, he is the editor-in-chief of ACS Biomaterials Science and Engineering, and he serves on many editorial boards and programs for journals and universities, and has received a number of awards for teaching and research.

Dr. Ali Khademhosseini, Terasaki Research Institute


Ali Khademhosseini is the CEO and Founding Director at the Terasaki Institute for Biomedical Innovation. He is also a researcher at Amazon Web Services Inc. Previously, he was a Professor of Bioengineering, Chemical Engineering and Radiology at the University of California-Los Angeles (UCLA). Previously, he was a Professor at Harvard Medical School and faculty at the Harvard-MIT’s Division of Health Sciences and Technology, Brigham and Women’s Hospital and an associate faculty at the Wyss Institute for Biologically Inspired Engineering. He received his Ph.D. in bioengineering from MIT, and MASc and BASc degrees from University of Toronto both in chemical engineering.

Prof. Dr. Mario Monzón, Universidad de Las Palmas de Gran Canaria


Dr. Mario Monzón is a full professor in the Mechanical Engineering Department of Las Palmas de Gran Canaria University . He is the coordinator of the research group of Integrated and Advanced Manufacturing, which main research fields are Polymer processing, additive manufacturing (AM), rapid tooling, natural fibres and applications in composite materials and technical textiles, circular economy, biomaterials for additive manufacturing and biofabrication. He is a member of the committee ISO TC261 and CEN TC438 for standardization of additive manufacturing technologies. Also, He is the convenor of the Joint working group JWG11 “Additive Manufacturing for Plastics”.

Dr. Uwe Marx, TissUse GmbH, Technische Universität Berlin


Since 2010 Uwe Marx is the CEO and founder of TissUse, a “Human-on-a-chip” spin-off company of the Technische Universität Berlin. He pioneered various programs in the “Multi-organ-chip” field. Between 2000 and 2010 Dr. Marx joined German the biotech ProBioGen, whichnhe founded in 1994, as the Chief Scientific Officer. Prior to that, he spent his scientific career at the University of Leipzig (1995-2000) and at the Charité Berlin (before 1995). He received his doctorate degree in immunology from the Humboldt University, Charité in Berlin. Dr. Marx has published more than 60 peer-reviewed papers and is inventor in 26 patent families. https://en.wikipedia.org/wiki/Uwe_Marx.

Prof. Dr. Masahiro Kino-oka, Department of Biotechnology, Osaka University

Masa (Masahiro KINO-OKA) is one of leaders in the field of cell manufacturing, who contributes to the standardization of the cell processing facility and manufacturing. His current research interests are “Bioprocess engineering” to establish the cell and tissue manufacturing system. Toward the current professional status, Masa earned the Ph.D. (chemical engineering) in 1996, and he spent one year as a visiting staff in the Department of Chemical Engineering, National Institute of Switzerland (ETH) in Zurich. After returning, he promoted twice in his five-year tenure, and he earned a current position of Professor in Biotechnology, Osaka University since 2009.

Dr. Nicholas Kurniawan, Eindhoven University of Technology

Dr. Nicholas Kurniawan is an Assistant Professor at the Department of Biomedical Engineering in Eindhoven University of Technology, the Netherlands. His research focuses on understanding how the physical and mechanical interactions between cells and cellular environments shape physiological tissue function and drive pathologies. His interdisciplinary team combines approaches from biophysics, mechanobiology, microfabrication, and cell biology with an outlook of exploiting cell–materials interactions for regenerative medicine applications. His work is supported by grants from the European Research Council, the Dutch Research Council, the Dutch Ministry of Economic Affairs and Climate Policy, and the Dutch Ministry of Education, Culture and Science.

Prof. Dr. Christine Le Maitre, Sheffield Hallam University


Christine is Professor of Cell biology and Tissue Regeneration and leads the Tissue Engineering and Biomechanics Research Group at Sheffield Hallam University, UK. Her research focuses on understanding the pathogenesis of musculoskeletal disorders and utilising this knowledge to develop novel therapeutic approaches. Her research to date has led to >20 million in research funding, 2 patent families, ~80 peer reviewed publications with a current H index of 34 and ~6000 citations on her work to date. She has supervised 14 doctoral students to completion and currently supervises 7 doctoral students.

Dr. Jianhao Lin, Peking University People's Hospital


Jianhao Lin is a leader in joint surgery in China, with research interests in the development of cartilage regeneration and joint reconstruction strategies. He is Head of the Arthritis Clinic and Research Center at Peking University, Chair of the Beijing Joint Health Foundation, and Chair of the Asian Alliances Committee of Osteoarthritis Research Society International (OARSI). His basic science research focuses on the physical microenvironment of MSCs and their applications in tissue engineering and regenerative medicine, particularly for musculoskeletal tissues. He serves on many journal editorial boards including HSS and OAC Open.

Dr. Claudia Loebel, University of Pennsylvania

Claudia Loebel is currently a postdoctoral fellow in the laboratory of Professor Jason Burdick at the University of Pennsylvania (United States). She obtained her MD (2011) at the Martin-Luther University Halle-Wittenberg (Germany) and completed her PhD (2016) at ETH Zurich and the AO Research Institute (Switzerland). She has been awarded the Silver Medal of ETH and postdoctoral fellowships by the Swiss National Science Foundation and IBSA Foundation. Her research interests are on the development of biomaterial platforms to address specific problems related to tissue repair and therapeutic treatment.

Prof. Dr. Henning Madry, Universität des Saarlandes, Lehrstuhl für Experimentelle Orthopädie und Arthroseforschung

- Clinician-scientist
- MD in 1996 from Humboldt University, Berlin
- Resident, Department of Trauma Surgery, Charité Medical School, Berlin and Department of Orthopaedic Surgery, Saarland University
- Board-certified in Orthopaedic Surgery in 2004
- Postdoctoral fellow: Massachusetts General Hospital, Harvard Medical School and Massachusetts Institute of Technology
- Since 2009 Full Professor and Director of the Center of Experimental Orthopaedics at Saarland University with joint appointment in Department of Orthopaedic Surgery
- Research focus: Fundamental and translational aspects of osteoarthritis and cartilage repair. Clinical practice: Regenerative surgical treatments for cartilage defects of the knee and osteoarthritis

Prof. João Mano, University of Aveiro


João F. Mano is a Full Professor at the Chemistry Department of University of Aveiro, Portugal. He is the director of the COMPASS Research Group, from the research unit CICECO – Aveiro Institute of Materials, focusing on the use of advanced biomaterials and cells towards the progress of transdisciplinary concepts to be employed in regenerative and personalised medicine. He is the Editor-in-Chief of Materials Today Bio (Elsevier). He has been coordinating several national and European research projects, including Advanced and Proof-of-Concept Grants from the European Research Council.

Prof. Eduardo Marbán Smidt, Heart Institute Cedars-Sinai Medical Center


Eduardo Marbán, MD, PhD, is an international leader in cardiology and a pioneering heart researcher. His 30-plus years of experience in patient care and research have led to key discoveries in gene- and cell-based therapies for heart disease. Those discoveries have formed the basis for multiple startup companies. In 2007, Marbán became founding director of the Cedars-Sinai Heart Institute, which was renamed the Smidt Heart Institute in 2018. The Smidt Heart Institute has been ranked by US News and World Report as the top heart program in the western USA since 2013.

Prof. Alvaro Mata, University of Nottingham

Alvaro Mata is Professor in Biomedical Engineering and Biomaterials in the School of Pharmacy and the Department of Chemical and Environmental Engineering at the University of Nottingham. He holds a Doctor of Engineering Degree working with Prof. Shuvo Roy at the Cleveland Clinic prior to postdoctoral training working with Prof. Samuel Stupp at Northwestern University. His group aims to harness biomolecules and supramolecular events found in nature to develop innovative materials and biofabrication processes. His work has led to seven patents or patent applications and publications in journals including Nature Materials, Nature Chemistry, Nature Communications, and Advanced Functional Materials.

Dr. Rikke Meyer, Aarhus University

Rikke Meyer is PhD in microbiology and Associate professor at the Interdisciplinary Nanoscience Center at Aarhus University, Denmark. She is heading a research group that studies now bacteria form biofilms, and how to prevent or treat biofilms by exploiting recent advancements in nanotechnology. Her research addresses the fundamental questions of how bacteria interact with material surfaces, and she brings this knowledge into application in collaboration with industry partners from the health, food, and water technology sectors.

Prof. David Mooney, Harvard University


David Mooney is the Pinkas Family Professor of Bioengineering in the Harvard School of Engineering and Applied Sciences, and a Core Faculty Member of the Wyss Institute. His laboratory designs biomaterials to promote regeneration and immunotherapy. He is a member of the National Academy of Engineering, the National Academy of Medicine, and the National Academy of Inventors. His inventions have been licensed by over 15 companies, leading to commercialized products. He has founded companies, and is active on industrial scientific advisory boards.

Prof. Dr. Christophe Moser, Ecole Polytechnique Federale de Lausanne


Christophe Moser is Associate professor of optics and Section Director in the MicroEngineering Institute at EPFL. His current research interests are micro-endoscopic imaging through multimode fibers, retinal imaging and additive manufacturing via volumetric 3D printing with light. His group developed a single photon volumetric 3D bioprinter technology capable of printing high resolution centimeter scale live cell laden complex constructs in matters of seconds by tomographic back-projection. He holds a PhD from Caltech and was the CEO of Ondax for 10 years prior to joining EPFL. He is the author and co-author of 75 peer reviewed publications and over 50 patents.

Prof. Francesco Nicotra, University of Milano-Bicocca

Francesco Nicotra professor of Organic Chemistry at University of Milano-Bicocca, Past-President of the IUPAC Division of Organic and Biomolecular Chemistry, Italian representative in the International Carbohydrate Organization. Scientific interests in Bio-organic chemistry, with particular attention to glycoscience. Recipient of the Award for innovation in research of the Italian Chemical Society; the Medal Berti for Research in Carbohydrate Chemistry and the Medal Quilico of the Division of Organic Chemistry of the Italian Chemical Society. Plenary and Keynote speaker in > 50 International Conferences. >200 publications, 18 chapters of books, 12 patents, H index 39 (Google Scholar), 34 (Scopus)

Prof. Dr. Aleksandr Ovsianikov, TU Wien


Prof. Aleksandr Ovsianikov is a head of the research group 3D Printing and Biofabrication at the TU Wien (Vienna, Austria). He is a member of the Austrian Cluster for Tissue Regeneration (http://www.tissue-regeneration.at) and was recently elected to the board of directors of the international society of biofabrication (https://biofabricationsociety.org). A particular focus his current research is the development of multiphoton lithography technologies for high-definition bioprinting of 3D cell culture matrices and realization of novel tissue engineering scaffolds. He was awarded prestigious European Research Council (ERC) Starting Grant in 2012 and a Consolidator Grant in 2017 for projects aimed at these topics.

Prof. Sean Palecek, University of Wisconsin - Madison

Prof. Sean Palecek is the Milton J. and Maude Shoemaker Professor of Chemical and Biological Engineering at the University of Wisconsin – Madison, the Director for Research for the National Center for Cell Manufacturing Technologies, and Director for Research Innovation of the Forward BIO Institute. Prof. Palecek’s research group develops processes for biomanufacturing of cells and tissues from human pluripotent stem cells, with a current focus on cardiovascular and neurovascular lineages. They strive to engineer robust, scalable platforms to produce high quality cells and tissues for in vitro diagnostics as well as regenerative medicine applications.

Prof. Dr. Chanhum Park, Hallym University

I graduated the Hallym Univsersity Medical School(M.D.) in 1996. He obtained Ph.D. degree from KangWon National University, Korea. I have been working in chief(associate professor) of the department of Otorhinolaryngology Head & Neck Surgery in Chunchon Sacred Heart Hospital of Hallym Medical Center from 2004. My major study’s field of medical part is the facial surgery and reconstruction such as rhinoplasty, facial trauma, skin cancer etc. I studied the biomaterials for facial reconstruction such as Gore-Tex, Silicone, metal plate, absorbable fixation plate etc. And I was developing biomaterials using silk fibroin from 2008

Dr. Qasim Rafiq, University College London

Dr Qasim Rafiq is an Associate Professor at University College London in Cell and Gene Therapy Bioprocessing. He is a multidisciplinary engineer and currently leads a research portfolio of >£3.5m and heads up the ATMP Bioprocess Engineering group which includes 4 PDRAs and 12 PhD students. He is the Programme Director of a new MSc programme in the Manufacture and Commercialisation of Stem Cell and Gene Therapies. He is both a Chartered Engineer (CEng) and Chartered Scientist (CSci) and sits on multiple scientific and engineering committees including the BIA’s Cell and Gene Therapy Advisory Committee and BSI’s Biotechnology Standards Group.

Prof. José Carlos Rodríguez-Cabello, Bioforge Lab. University of Valladolid

Full Professor of condensed Matter Physics and CEO of Technical Proteins NBT S.L.. Expert in biomaterials and biomedical engineering. My research interest lies on the recombinant production of bioinspired polypeptides and the use of those designed macromolecules in a broad range of applications from more basic science around self-organization and order-disorder interplay in natural proteins to the use of such materials in regenerative medicine and nanomedicine.

Prof. Steffen Scholpp, Living Systems Institute, University of Exeter


After secretion, developmental signals such as the Wnt morphogens must travel relatively long distances to form a concentration gradient that the responding tissue uses to acquire positional information. The role of Wnt transport and endocytic trafficking in this process is the subject of intense debate. My team has shown that Wnt is transported on long, actin-based filopodia - known as cytonemes to contact responding cells and activate signalling in human gastric tumour tissue and zebrafish embryogenesis. We are in the process of deciphering the molecular mechanism controlling cytoneme formation and the consequences on cell signalling and tissue development and homeostasis.

Prof. Hazel Screen, Queen Mary University of London

Hazel Screen is Professor of Biomedical Engineering at Queen Mary University of London. Her research centres on healthy and pathological tissue structure-function behaviour and its interplay with mechanobiology. She has a particular interest in tendon and ligament, and leads a highly multidisciplinary group which spans human and animal in vivo and in vitro studies of tendon function and injury. She also leads the UK Organ-on-a-Chip Technologies Network and is interested in developing novel in vitro models of musculoskeletal tissues which integrate learning from structure-function studies to recapitulate appropriate physiochemical cues.

Prof. Toshiharu Shinoka, Nationwide Children's Hospital


1983 M.D. Hiroshima University, School of Medicine 1994-1997 Research fellows in Children's Hospital, Boston, Harvard Medical School 1998- 2001 Assistant Professor, Department of Pediatric Cardiovascular Surgery, Tokyo Women's Medical University 2001-2004 Associate Professor, The institute of Advanced Biomedical Engineering & Science, Tokyo Women’s Medical University 2004-2006 Professor, Division of Cardiovascular Tissue Engineering, Tokyo Women’s Medical University 2007-present Visiting Professor, Department of Cardiovascular Surgery, Tokyo Women’s Medical University 2007-2012 Director of Pediatric Cardiovascular Surgery, Yale New Haven Hospital 2012-present Professor of Surgery, Ohio Stage University Director of Cardiovascular Tissue Engineering Program, Nationwide Children’s Hospital

Prof. Heungsoo Shin, Hanyang University


Heungsoo Shin is currently a professor in the Department of Bioengineering, Hanyang University, South Korea. He received his Ph.D. in the Department of Bioengineering from Rice University, USA (2004), and was a postdoctoral researcher at the Department of Mechanical Engineering, Georgia Institute of Technology, USA. The main research thrusts in his laboratory include 1) development of biomimetic materials for cell and growth factor delivery in tissue engineering, 2) 3D culture and stem cell engineering, and 3) characterization of cell‐extracellular matrix interactions. His works particularly have led to innovative approaches in the regeneration of impaired musculoskeletal tissue.

Prof. John H Slater, University of Delaware - Biomedical Engineering

Dr. Slater received a BS in Mechanical Engineering from the University of North Carolina at Charlotte, graduating Magna Cum Laude, where he received the Danielson Endowment and the James S. Jones Memorial Scholarships. He earned a PhD in Biomedical Engineering with a Portfolio Degree in Nanoscience and Nanotechnology from the University of Texas where he was a NSF Graduate Research, Biomedical Engineering Tom Collins, and a Thrust Fellow. He was a NIH Nanobiology Postdoctoral Fellow and a HHMI Postdoctoral Fellow in the Bioengineering Department at Rice University. He is an Associate Professor of Biomedical Engineering at the University of Delaware.

Prof. Dr. Dimitrios Stamatialis, University of Twente

Prof. Dr. Dimitrios Stamatialis obtained his PhD at NRC “Demokritos” (Athens - Greece) in 1995 in the field of physical chemistry and membranes. He is full professor of (bio)artificial organs at the University of Twente in the Netherlands.
Prof. Stamatialis has been involved in numerous projects leading to products and applications, some licensed to companies. He is author of more than 145 scientific papers and inventor of 9 patents. He has various international activities, including: Chairman of the working group on bioartificial organs of the European Society of artificial organs (ESAO) and editor of the “international journal of artificial organs”.

Prof. Dr. Yasuhiko Tabata, Institute for Frontier Life and Medical Sciences, Kyoto University

Dr. Yasuhiko Tabata is the Professor of Institute for Frontier Life and Medical Sciences, Kyoto University and guest professors of 17 different universities. He received his BD in Polymer Chemistry (1981), Ph.D. (1988) in Technology, D.Med.Sc. (2002), and D.Pharm. (2003) all at Kyoto University. He was a Visiting Scientist at the MIT (Professor Robert Langer) (1991-92). He has published 1,630 scientific papers including 145 book chapters and review articles, and has 130 patents. He received the Scientific Award from the Japanese Society for Biomaterials (2002), the Japan Society of Drug Delivery System (2011), TERMIS-AP (2018), and 5 other scientific awards.

Prof. Maryam Tabrizian, McGill University


Maryam Tabrizian is Canada Research Chair holder in Regenerative Medicine and Nanomedicine, cross-appointed between Faculty of Medicine-Biomedical Engineering Department and the Faculty of Dentistry at McGill University. She was the founding director of the Centre for Biorecognition and Biosensors and has received many prestigious awards (Career award, Guggenheim foundation, Biomaterials Science & Engineering, RSC-Academy of Science, ADEA Leadership Institute, Canadian Academy of Health Sciences,..). She is expertise in the design of advanced biomaterials and biointerfaces for their applications in nanomedicine, regenerative medicine and Lab-on-a-chip devices. Professor Tabrizian authored over 235 papers (H-index 61) and is the EIC of Materials (MDPI).

Dr. Masayo Takahashi, Vision Care Inc.

Masayo Takahashi received her M.D. and Ph.D. from Kyoto University. She moved to the Salk Institute, where she discovered the potential of stem cells as a tool for retinal therapy. She joined RIKEN as a Team Leader. In 2013, her team launched a pilot clinical study of autologous iPS cell-derived RPE cell sheets for exudative aged-related macular degeneration, and performed the first RPE cell sheet graft transplantation in 2014. In 2019, she started a new carrier as a president of start-up company; Vision Care Inc. Her aim is to understand these diseases at a fundamental level and develop retinal therapies.

Dr. Hironobu Takahashi, Tokyo Women's Medical University

Dr. Takahashi is now an associate professor of Institute of Advanced Biomedical Engineering and Science at Tokyo Women’s Medical University (TWMU). He graduated from Department of Engineering, Kyushu University and received Ph.D. in 2006. He then performed postdoctoral research under Prof. David Grainger, Colorado State University and University of Utah, USA. His researches was the development of a hydrogel-based local drug delivery system and cell micropatterning techniques. After that, he moved to TWMU and started researches for tissue engineering and regenerative medicine in 2008. His recent work is focused on muscle tissue engineering for the development of in-vitro tissue model.

Prof. Pierre vanderhaeghen, VIB Belgium

Pierre Vanderhaeghen is Professor at the VIB Center for Brain and Disease Research at KU Leuven, and Université Libre de Bruxelles, Belgium. His research is focused the mechanisms of development of the cerebral cortex in direct link with human brain evolution and diseases. His lab uses classical tools such as mouse genetics and embryology, as well as innovative models of corticogenesis from pluripotent stem cells, which were pioneered in his lab.

Dr. Joaquim Vives, Banc de Sang i Teixits

I am a Biochemist with extensive experience in the R&D biotech sector, both in private and academic environments. I focused my career on the optimisation of cellular processes towards A) high yield production of diagnostic and therapeutic molecules, and B) the development of methods to produce cells for drug screening and therapy, in compliance with current regulatory and quality standards. Apart from leading MTA production for clinical trials, I focus my research in A) the generation of 3D tissue engineering products, B) the development of animal models for the study of tissue regeneration and identification of biomarkers of tissue remodelling.

Dr. Yoram Vodovotz, University of Pittsburgh

Dr. Yoram Vodovotz is currently a Professor of Surgery, Immunology, Computational and Systems Biology, Bioengineering, Clinical and Translational Science, and Communication Science and Disorders at the University of Pittsburgh School of Medicine. His research focus is the systems biology of inflammation. He is the Director of the Center for Inflammation and Regeneration Modeling (CIRM; http://www.mirm.pitt.edu/our-research/centers/center-for-inflammation-an...) at the McGowan Institute for Regenerative Medicine, a co-founder and past President of the Society for Complex Acute Illness (www.scai-med.org), and a co-founder of Immunetrics, Inc. (www.immunetrics.com), a Pittsburgh-based company that is commercializing this mathematical modeling work. He has published over 300 manuscripts.

Prof. Slobodan Vukicevic, Laboratory for Mineralized Tissues, Center for Translational and Clinical Research, University of Zagreb School of Medicine

Slobodan Vukicevic is a full professor and head of Laboratory of Mineralized Tissues, Center for Translational and Clinical Research, University of Zagreb School of Medicine. He is a full member of the Croatian Academy of Sciences and Arts. His scientific interests comprise bone and cartilage morphogenetic proteins and development of drugs for regeneration of bone, kidney and heart muscle. Inventor of more than 30 patents and editor of 4 books on BMPs. Founder of Genera Research, innovation-based biotechnology company developing a novel regenerative therapy for bone defects via coordinating collaborative programs OSTEOGROW (FP7) and OSTEOproSPINE (HORIZON 2020).

Prof. Wolfgang Wagner, RWTH Aachen Medical School

Wolfgang Wagner is Professor of Stem Cell Biology and Cellular Engineering at RWTH Aachen University Medical School (Germany) since 10 years. Furthermore, he is cofounder of the company Cygenia (www.cygenia.com) that provides service for epigenetic analysis for other scientists since 2014. Prof. Wagner is Editor of the journals PLoS ONE, Scientific Reports and Clinical Epigenetics. His main research interests are 1) epigenetics in hematopoietic differentiation; 2) standardization and characterization of mesenchymal stem cells; 3) interaction of stem cells with biomaterials; and 4) molecular and epigenetic effects of aging, replicative senescence, and malignant transformation.

Dr. Gerlinde Van De Walle, Cornell university

Dr. Van de Walle received her DVM degree from the Faculty of Veterinary Medicine, Ghent University, Belgium, followed by a PhD from the same institution. She is currently an Associate Professor at the Baker Institute for Animal Health, Cornell University, where she runs her research lab working in the fields of Virology and Stem Cell Biology. In 2016, she was awarded the Zoetis Animal Health Award for Research Excellence, and was named the Harry M. Zweig Assistant Professor in Equine Health in 2017. She has published over 100 papers in peer-reviewed journals and presented at numerous national and international conferences.

Prof. Matthew Webber, University of Notre Dame

Assistant Professor of Chemical & Biomolecular Engineering, University of Notre Dame, USA.

Prof. Dr. Tanja Weil, Max Planck Institute for Polymer Research

Prof. Dr. Tanja Weil joined the Max Planck Society in 2017 as one of the directors of the Max Planck Institute for Polymer Research, heading the division “Synthesis of Macromolecules”. She studied chemistry (1993–1998) at the TU Braunschweig (Germany) and the University of Bordeaux I (France) and completed her PhD at the MPI for Polymer Research under the supervision of K. Müllen. Her scientific interests focus on innovative synthesis concepts to achieve functional macromolecules and hybrid materials to solve current challenges in biomedicine and material science.

Prof. Dr. Anthony Weiss, University of Sydney


Professor Weiss is the McCaughey Chair in Biochemistry, NHMRC Leadership Fellow, and leads Tissue Engineering & Regenerative Medicine at the CPC University of Sydney. Awards include the Eureka Prize for Innovation in Medical Research, Clunies Ross Knowledge Commercialisation Award, NSW Premier’s Prize for Science & Engineering Leadership in Innovation, Vice Chancellor’s Award for Excellence, Innovator of Influence Award, Applied Research Medal, and the Order of Australia. He is a Fellow of the Royal Society of Chemistry, Australian Academy of Technology and Engineering, Royal Australian Chemical Institute, Royal Society of NSW, AIMBE, Tissue Engineering and Regenerative Medicine, Biomaterials Science and Engineering.

Prof. Dr. Regine Willumeit-Römer, Helmholtz Zentrum Geesthacht, Metallische Biomaterialien

R. Willumeit-Römer studied and obtained a PhD in physics by working on the structure of ribosomes. Habilitation and venia legendi in biochemistry. After working on peptide antibiotics and antimicrobial implant surfaces focus on degradable Mg-based implants. Current position: Director of the Institute for Materials Research, Divison Metallic Biomaterials, Helmholtz-Center Geesthacht and Professor at the Faculty of Engineering, Christian-Albrechts-University, Kiel, Germany.      

Prof. Dr. Tobias Winkler, Universitätsmedizin Berlin / Regenerative Orthopädie und Unfallchirurgie

Prof. Dr. Tobias Winkler is orthopedic and trauma surgeon at the Center for Muskuloskeletal Surgery (CMSC) of the Charité Berlin. He is coordinator of an international research consortium performing the worldwide only phase III trial of an allogeneic cell therapy for regeneration after skeletal muscle injury. He is head of a research team, which main focus is the translation of advanced therapies for musculoskeletal indications. His research work in the field encompasses cell therapies with adult mesenchymal and blood cells for bone tendon and muscle regeneration and the development of biomaterials for bone regeneration.

Dr. Yang Zhang, Shenzhen University

Yang Zhang obtained his Ph.D. degree and postdoctoral experience from Radboud University Medical Center, the Netherlands. After that, he joined Shenzhen University as an associate professor. His current research focuses on unraveling roles of the immune microenvironment in tissue regeneration, where he has published more than 20 journal articles. He served as a 29th ESB Academic Committee member and as a peer reviewer for Biomaterials Science, Tissue Engineering, Journal of Biomedical Materials Research, etc. He was also a visiting researcher at Johannes Gutenberg University Mainz (Germany) and Capital Medical University (China).
 
Prof. Dr. Y. Shrike Zhang, Harvard Medical School


Dr. Zhang's research interests include 3D bioprinting, organ-on-a-chip, regenerative engineering, and bioanalysis. His scientific contributions have been recognized by >40 awards. He is an author of >190 peer-reviewed publications (H-index: 53) and has delivered >110 invited lectures globally. He is serving as Co-Editor-in-Chief for Microphysiological Systems, and is an Associate Editor for Bio-Design and Manufacturing, Essays in Biochemistry, and Nano Select. He is also on the Editorial Board of Biofabrication, Bioprinting, Advanced Healthcare Materials, BMC Materials, and Chinese Chemical Letters, and Editorial Advisory Board of Heliyon and Biomicrofluidics, and Advisory Panel of Nanotechnology.